The global protein labelling market size is estimated to be worth USD 3.07 billion by 2027 from USD 1.73 billion in 2022, growing at a CAGR of 12.2% during the forecast period.
Protein labelling is the process of detecting a labelled protein and its binding partners by using the proper molecular labels. Different compounds, including biotin, reporter enzymes, and radioactive isotopes, are tightly bound to the target protein or nucleotide sequence using labelling methods. Proteins are the largest and most important biomolecules in a living organism, as they are essential for survival. Proteins interact with other biomolecules and carry out tasks to keep the cell alive after they are produced within a cell. The usage of non-canonical amino acids (ncAAs) followed by conjugation of labelled protein with fluorophores, polymers, affinity reagents, peptides, or nanoparticles has been demonstrated to be successful in proteomics and biotechnology.
Protein labeling is becoming increasingly popular. Protein labelling employs a short label to prevent protein folding and function from being disturbed. Immunochemistry, fluorescence in situ hybridization (FISH), cell tracking, receptor tagging, and fluorescence spectroscopy are just a few of the uses for these fluorescent proteins. In addition, biological process monitoring, accurate compound quantification, precise detection of protein changes and isoforms in multiplexed samples, increased detection sensitivity, and simplified detection procedures are some of the most common uses for protein labeling use of IT technology is intended to automate and simplify research and development, as well as increase experimentation and research.
MARKET DRIVERS:
Innovation is playing a significant role in the global protein labelling market growth.
Chemically synthesized tags replace reagent and Kit-based protein labeling, probes, and tags through click chemistry and other newer and improved technologies. In addition, synergistic advances in optical physics, probe design, molecular biology, and computational analysis have resulted in the design and development of new protein-labeling technologies that have the potential to propel the future protein labeling market profitably.
Additionally, factors such as increasing health care awareness, rising R&D expenditure, growing technological advancements, innovative products, applications, and services, and the development of proteomics coupled with the development of protein sequencing techniques further accelerate the growth rate of the global protein labelling market. Moreover, computer-controlled systems for fluorescence and laser-confocal microscopy are also creating scope for the market.
Increasing government's focus on improving the healthcare infrastructure, increasing proteomics research, and increasing research and development spending for the research activities are expected to provide a favorable environment to the global protein labelling market to explore further. Adopting modern molecular biology and bioengineering tools to intensify functional mechanism knowledge on a subcellular scale, under both pathologic and psychologic conditions, leads to drug development, diagnosis, and therapy applications. With the bioengineering tools, the usage label in the detection & purification of proteins and diagnostic tests based on detecting a particular protein has grown significantly. The market represents several new product launches, and the rising adoption of bioengineering technologies is expected to accelerate the market growth.
MARKET RESTRAINTS:
However, lack of skilled professionals and awareness, and high costs of products hinder the global protein labelling market growth.
Impact of COVID-19 on the global protein labeling market:
The current debacle of COVID-19, with a constantly clambering number of deaths across various nations, led to the nationwide lockdown. In the battle against the novel coronavirus, governments imposed a ban on flights and other transportation to stop virus transmission from person to person. Due to the prohibition on transportation, the protein labeling market supply chain had been disrupted. The protein labeling market consists of sales of protein labeling products and related services; because of the sudden implementation of lockdown and ban, no sales were made during the first quarter of 2020. As a result, there were some limitations on the exports and imports of protein labeling products.
However, the second quarter of 2020 was acted favorably to the protein labelling market. The factors such as the uplift of lockdown resumed activities, and increasing demand for the protein label products are expected to boost the market growth. Furthermore, post the outbreak, and the market has completely changed; therefore, manufacturing industries manufacture the products as per the customers' needs. As a result, analysts at Market Data Forecast forecasted the global protein labelling market to return to its actual growth pace by the end of 2021.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021 to 2027 |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2027 |
|
Segments Analysed |
By Product, Labelling, Application, and Region |
|
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Companies Analysed |
Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc. |
This research report on the global protein labelling market has been segmented and sub-segmented based on the product, labelling, application, and region.
Protein Labelling Market - By Product:
Based on Product, Reagents had the highest market share in 2020. In-vitro labelling accounted for a larger revenue share due to ongoing clinical investigation studies concerning the proteomic analysis of genetic data. As a result, an increase in the number of labeling agents and genetically engineered labels is discovered, expected to calculate the percentage of the reagents segment. In the reagent segment, the protein segment held a significant share for protein labeling in terms of revenue share.
Protein Labelling Market - By Labelling:
The vitro labeling segment is estimated to account for the majority market share during the forecast period based on the labeling. Reagents, instruments, and systems are intended for use in the diagnosis of diseases and other conditions. The in vitro labeling procedure takes approximately 25 minutes and doesn’t require centrifugation to separate from bound 99mtc.
Protein Labelling Market - By Application:
Based on the application, the Immunological techniques segment represents the largest segment with a higher market share. Flow cytometry, immunoassays, western blotting, and immunofluorescence are immunological techniques involved in using labels. These techniques are mostly being used in cancer research and autoimmune disease research, and therapeutics development.
Protein Labelling Market - By Region:
Based on the Region, North America generated the highest revenue in 2020 and has the maximum share of the global protein labelling market due to the technological advancements, demand for protein labelling products, and rise in R&D investments. Furthermore, North America is estimated to dominate the global market, with Europe and Asia-Pacific in the line due to the significant rise in funding.
The Asia-Pacific is the fastest-growing region due to the increased demands of emerging economies such as Japan, India, and China, rising investment in genomic and proteomic research, and a rise in healthcare expenditure.
KEY MARKET PLAYERS:
Some of the notable companies dominating the global protein labelling market profiled in this report are Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.
RECENT MARKET DEVELOPMENTS:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Reagents
5.1.2.1 Enzymes
5.1.2.2 Monoclonal Antibodies
5.1.2.3 Proteins
5.1.2.4 Probes/Tags
5.1.2.5 Other Reagents
5.1.3 Kits
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Labeling Method
5.2.1 Introduction
5.2.2 In vitro Labeling
5.2.2.1 Enzymatic Labeling
5.2.2.2 Dye-Based Labeling
5.2.2.3 Cotranslational Labeling
5.2.2.4 Site-Specific Labeling
5.2.2.5 Nanoparticle Labeling
5.2.3 In vivo Labeling
5.2.3.1 Photoreactive Labeling
5.2.3.2 Radioactive Labeling
5.2.4 Bioorthogonal Labeling
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Cell-Based Assay
5.3.3 Mass Spectroscopy
5.3.4 Fluorescence Microscopy
5.3.5 Immunological Technique
5.3.6 Protein Microarray
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End user
5.4.1 Introduction
5.4.2 Y-o-Y Growth Analysis, By End user
5.4.2 Market Attractiveness Analysis, By End user
5.4.3 Market Share Analysis, By End user
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Labeling Method
6.1.3.4 By Application
6.1.3.5 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Labeling Method
6.1.4.4 By Application
6.1.4.5 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Labeling Method
6.1.5.4 By Application
6.1.5.5 By End user
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 General Electric Company
8.3 Merck KGaA
8.4 Eurogentec S.A.
8.5 PerkinElmer, Inc.
8.6 F. Hoffmann-La Roche AG
8.7 New England Biolabs
8.8 Kaneka Corporation
8.9 Kirkegaard & Perry Laboratories
8.10 Promega Corporation
8.11 LI-COR, Inc.
8.12 SeraCare Life Sciences, Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
